A nationwide survey of mortality in acromegaly

Journal of Clinical Endocrinology and Metabolism

Volumn 90, Issue 7, 2005, Pages 4081-4086

  Kauppinen Mäkelin, Ritva ^a   Sane, Timo ^b   Reunanen, Antti ^c   Välimäki, Matti J ^b   Niskanen, Leo ^d   Markkanen, Helene ^b   Löyttyniemi, Eliisa ^e   Ebeling, Tapani ^f   Jaatinen, Pia ^g   Laine, Hanna ^h   Nuutila, Pirjo ^h   Salmela, Pasi ^f   Salmi, Jorma ^g   Stenman, Ulf Håkan ^b   Viikari, Jorma ^h   Voutilainen, Erkki ^d  

^a JORVI HOSPITAL   (Finland)

^b HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^c NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^d KUOPIO UNIVERSITY HOSPITAL   (Finland)

^e UNIVERSITY OF TURKU   (Finland)

^f OULU UNIVERSITY HOSPITAL   (Finland)

^g TAMPERE UNIVERSITY HOSPITAL   (Finland)

^h TURKU UNIVERSITY HOSPITAL   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH HORMONE; SOMATOMEDIN C;

ACROMEGALY; ADULT; ARTICLE; CONFIDENCE INTERVAL; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; LIFESPAN; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; SURVIVAL; TREATMENT OUTCOME; UNIVERSITY HOSPITAL;

ACROMEGALY; ADOLESCENT; ADULT; AGED; CAUSE OF DEATH; FEMALE; FINLAND; HUMAN GROWTH HORMONE; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; TREATMENT OUTCOME;

EID: 23044487111     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.2004-1381     Document Type: Article

References (22)

1. Wright AD, Hill DM, Lowy C, Fraser TR 1970 Mortality in acromegaly. Q J Med 34:1-16
2. Alexander L, Appleton D, Hall R, RossWM,Wilkinson R 1980 Epidemiology of acromegaly in the Newcastle region. Clin Endocrinol (Oxf) 12:71-79
3. Bengtsson B, Eden S, Ernest I, Oden A, Sjögren B 1988 Epidemiology and long term survival in acromegaly. A study of 166 cases diagnosed 1955 and 1984. Acta Med Scand 223:327-335
4. Bates AS, Van't Hoff W, Jones JM, Clayton RN 1993 An audit of outcome of treatment in acromegaly. Q J Med 86:293-299
5. Abosch A, Tyrrell JB, Lamborn KR, Hannegan LT, Applebury CB, Wilson CB 1998 Transspenoidal microsurgery for growth hormone-secreting pituitary adenomas: initial outcome and long-term results. J Clin Endocrinol Metab 83:3411-3418
6. Orme SM, McNally RJQ, Cartwright RA, Belchetz PE, for the United Kingdom Acromegaly Study Group 1998 Mortality and cancer incidence in acromegaly: a retrospective cohort study. J Clin Endocrinol Metab 83:2730-2734
7. Swearingen B, Barker 2nd FG, Katznelson L, Biller BK, Grinspoon S, Klibanski A, Moayeri N, Black PM, Zervas NT 1998 Long-term mortality after transspenoidal surgery and adjunctive therapy for acromegaly. J Clin Endocrinol Metab 83:3419-3426
8. Beauregard C, Truong U, Hardy J, Serri O 2003 Long-term outcome and mortality after transsphenoidal adenomectomy for acromegaly. Clin Endocrinol (Oxf) 58:86-91
9. Ayuk J, Clayton RN, Holder G, Sheppard MC, Stewart PM, Bates AS 2004 Growth hormone and pituitary radiotherapy, but not serum insulin-like growth factor-1 concentrations, predict excess mortality in patients with acromegaly. J Clin Endocrinol Metab 89:1613-1617
10. Mestrón A, Webb SM, Astorga R, Benito P, Catalá M, Gaztambide S, Gómez J-M, Halperí I, Lucas-Morante T, Moreno B, Obiols G, de Pablos P, Páramo C, Picó A, Torres E, Varela C, Vázquez J-A, Zamora J, Albareda M, Montserrat G, on behalf of all the REA participants 2004 Epidemiology, clinical characteristics, outcome, morbidity and mortality in acromegaly based on the Spanish Acromegaly Registry (Registro Español de Acromegalia, REA). Eur J Endocrinol 151:439-446
11. Holdaway IM, Rajasoorya RC, Gamble GD 2004 Factors influencing mortality in acromegaly. J Clin Endocrinol Metab 89:667-674
12. Nabarro JDN 1987 Acromegaly. Clin Endocrinol (Oxf) 26:481-512
13. Rajasoorya C, Holdaway IM, Wrightson P, Scott DJ, Ibbertson HK 1994 Determinants of clinical outcome and survival of acromegaly. Clin Endocrinol (Oxf) 41:95-102
14. Arita K, Kurisu K, Tominaga A, Eguchi K, Iida K, Uozumi T, Kasagi F 2003 Mortality in 154 surgically treated patients with acromegaly - a 10-year follow-up survey. Endocr J 50:163-172
15. Seth J, Ellis A, Al-Sadie R 1999 Serum growth hormone measurements in clinical practice: an audit of performance from the U.K. National External Quality Assessment Scheme. Horm Res 51(Suppl 1):13-19
16. 1993 Life tables, 1986-1990. Helsinki: Statistics Finland
17. Breslow NE, Day NE 1987 Rates and rate standardization. In: Breslow NE, Day NE, eds. Statistical methods in cancer research. Lyon, France: International Agency for Research on Cancer; 65-72
18. Biermasz NR, Dekker FW, Pereira AM, van Thiel SW, Schutte PJ, van Dulken HR, Romijn JA, Roelfsema F 2004 Determinants of survival in treated acromegaly in a single center predictive value of serial insulin-like growth factor I measurements. J Clin Endocrinol Metab 89:2789-2796
19. Rosén T, Bengtsson B-A 1990 Prematurity mortality due to cardiovascular disease in hypopituitarism. Lancet 336:285-288
20. Tomlinson JW, Holden N, Hills RK, Wheatley K, Clayton RN, Bates AS, Sheppard MC, Stewart PM 2001 Association between premature mortality and hypopituitarism. West Midlands Prospective Hypopituitary Study Group. Lancet 357:425-431
21. Erfurth EM, Bülow B, Svahn-Tapper G, Norrving B, Odh K, Mikoczy Z, Björk J, Hagmar L 2002 Risk factors for cerebrovascular deaths in patients operated and irradiated for pituitary tumors. J Clin Endocrinol Metab 87:4892-4899
22. Brunner JE, Johnson CC, Zafar S, Peterson EL, Brunner JF, MellingerRC1990 Colon cancer and polyps in acromegaly: increased risk associated with family history of colon cancer. Clin Endocrinol (Oxf) 32:65-71